Finished product reference
Miconazole Nitrate
Cream · Topical · 2 % · 40 g
- List code
- 51996
Indications
Uses for the treatment of most athlete's foot (tinea pedis), jock itch (tinea cruris), ringworm (tinea corporis) relieves most itching, scaling, cracking, burning, redness, soreness, irritation, discomfort and chafing associated with jock itch
Dosage and administration (summary)
Directions Clean the affected area and dry thoroughly Apply a thin layer of powder over affected area twice daily (morning and night) or as directed by a doctor Supervise children in the use of this product For athlete's foot, pay special attention between spaces in toes; wear well-fitting, ventilated shoes, and change shoes and socks at least once daily For athlete's foot and ringworm, use daily for 4 weeks For jock itch, use daily for 2 weeks If condition persists longer, consult a doctor This product is not effective on the scalp or nails.
Warnings and precautions
Warnings For external use only Do not use on children under 2 years of age unless directed by a doctor on scalp or nails When using this product avoid contact with the eyes Stop use and ask a doctor if irritation occurs there is no improvement within 4 weeks when used for the treatment of athlete's foot or ringworm there is no improvement within 2 weeks when used for the treatment of jock itch Keep out of reach of children If swallowed, get medical help or contact a Poison Control center right away.
Storage and supply
Other Information protect from freezing. Avoid excessive heat. do not use if package is damaged keep dry
Source: Miconazole Nitrate (Remedy Antifungal) — US FDA prescribing information, 2025-10-29, DailyMed. Summarised and shortened; the full label governs. Iranian registration, indications and labelling may differ.
Other presentations of the same active ingredient
Reference information for professional sourcing and registration enquiries, not medical advice or a promotion. Drug information is condensed from US FDA prescribing information (public domain, via openFDA and DailyMed) and does not replace the product’s approved labelling in Iran. Availability, origin and documentation are confirmed per enquiry.
Tell us the quantity, the market and the timing.
Send the molecule or ingredient, the specification and the destination. We reply from Tehran with the questions, the documents and the next step.